» Articles » PMID: 18313805

Tetrahydronaphthyl Azole Oxime Ethers: the Conformationally Rigid Analogues of Oxiconazole As Antibacterials

Overview
Journal Eur J Med Chem
Specialty Chemistry
Date 2008 Mar 4
PMID 18313805
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

A series of novel (Z)- and (E)-2-imidazolo-/triazolo-methyl tetrahydronaphthyl oxime ethers (7-28) were synthesized as conformationally constrained analogues of oxiconazole and evaluated for antifungal and antibacterial activities. Many of these derivatives exhibited potent antibacterial activity and surprisingly none of them was active against fungal strains. The SAR studies showed that imidazole oxime ethers were more active than the corresponding triazole oxime ethers. Imidazole derivatives 8, 11, 12, 15, 18, 19, 21 and 23 exhibited high inhibitory activity with 1.56-0.39 microg/mL MIC values against Klebsiella pneumoniae, Escherichia coli and Staphylococcus aureus. These compounds represent new structure scaffolds that can be further optimized to give new antibacterial agents with structures significantly different from those of existing classes of antibiotics.

Citing Articles

Imidazole-Derived Alkyl and Aryl Ethers: Synthesis, Characterization, In Vitro Anticancer and Antioxidant Activities, Carbonic Anhydrase I-II Inhibition Properties, and In Silico Studies.

Faris M, Bostanci H, Ozcan I, Ozturk M, Kocyigit U, Erdogan T ACS Omega. 2024; 9(19):20937-20956.

PMID: 38764643 PMC: 11097166. DOI: 10.1021/acsomega.4c00028.


A Review of Biologically Active Oxime Ethers.

Kosmalski T, Kupczyk D, Baumgart S, Paprocka R, Studzinska R Molecules. 2023; 28(13).

PMID: 37446703 PMC: 10343442. DOI: 10.3390/molecules28135041.


Oxiconazole Potentiates Gentamicin against Gentamicin-Resistant Staphylococcus aureus and .

Kaul G, Akhir A, Shukla M, Shafi H, Akunuri R, Pawar G Microbiol Spectr. 2023; 11(4):e0503122.

PMID: 37428033 PMC: 10433863. DOI: 10.1128/spectrum.05031-22.


Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2.

Johnson T, Adegboyega A, Iwaloye O, Eseola O, Plass W, Afolabi B J Pharmacol Sci. 2021; 147(1):62-71.

PMID: 34294374 PMC: 8141268. DOI: 10.1016/j.jphs.2021.05.004.


Novel (+)-Neoisopulegol-Based -Benzyl Derivatives as Antimicrobial Agents.

Le T, Huynh T, Bamou F, Szekeres A, Fulop F, Szakonyi Z Int J Mol Sci. 2021; 22(11).

PMID: 34073167 PMC: 8198684. DOI: 10.3390/ijms22115626.